Data derived from PhenomiR
PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
16966691 |
Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) |
Cancer |
pancreas |
miRNA overexpression |
- |
6.61 |
- |
Patient study phenotype-control |
miRNA microarray
|
17761882 |
Parkinson disease - 168600 |
Neurological |
midbrain |
miRNA overexpression |
- |
1.44 |
- |
Patient study phenotype-control |
quantitative PCR
|
18458333 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary |
miRNA downregulation |
- |
- |
- |
Cell culture study |
miRNA microarray
|
18381414 |
Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) |
Cancer |
HSC-3 cell |
miRNA downregulation |
- |
- |
- |
Cell culture study |
quantitative PCR
|
18089852 |
Rapp-Hodgkin syndrome - 129400 |
multiple |
lymph node |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
18442408 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary cancer cell |
miRNA overexpression |
- |
8.15 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
17942673 |
Duchenne muscular dystrophy - 310200 |
Muscular |
muscle |
miRNA overexpression |
- |
8.56 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
4.85 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2A - 253600 |
Muscular |
muscle |
miRNA overexpression |
- |
6.33 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2B - 253601 |
Muscular |
muscle |
miRNA overexpression |
- |
7.77 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Miyoshi myopathy - 254130 |
Muscular |
muscle |
miRNA overexpression |
- |
4.39 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Myopathy, nemaline, 3 - 161800 |
Muscular |
muscle |
miRNA overexpression |
- |
30.09 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (Dermatomyositis - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
4.53 |
- |
Patient study phenotype-control |
miRNA microarray
|
17998940 |
Cervical cancer, somatic - 603956 |
Cancer |
CaSki cell |
miRNA downregulation |
- |
7.6 |
- |
Cell culture study |
miRNA microarray
|
17998940 |
Cervical cancer, somatic - 603956 |
Cancer |
HeLa cell |
miRNA downregulation |
- |
5.6 |
- |
Cell culture study |
miRNA microarray
|
17976522 |
Myelofibrosis, idiopathic - 254450 |
Hematological |
granulocyte |
miRNA overexpression |
- |
10.02 |
- |
Patient study phenotype-control |
quantitative PCR
|
18307259 |
Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) |
Cancer |
liver |
miRNA downregulation |
- |
25.0 |
- |
Patient study phenotype-control |
quantitative PCR
|
18728182 |
Immunological - 0 (Monoclonal gammopathy of undetermined significance (MGUS) - 0) |
Immunological |
plasma cell |
miRNA overexpression |
- |
6.9 |
- |
Patient study phenotype-control |
miRNA microarray
|
18728182 |
Multiple myeloma - 254500 |
Cancer |
plasma cell |
miRNA overexpression |
- |
9.03 |
- |
Patient study phenotype-control |
miRNA microarray
|
16754881 |
Breast cancer - 114480 |
Cancer |
breast epithelium |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA downregulation |
- |
- |
- |
Cell culture study |
array CGH
|
17761882 |
Parkinson disease - 168600 |
Neurological |
cerebellar cortex |
miRNA downregulation |
- |
1.53846 |
- |
Patient study phenotype-control |
quantitative PCR
|
17761882 |
Parkinson disease - 168600 |
Neurological |
cerebellum |
miRNA overexpression |
- |
3.2 |
- |
Patient study phenotype-control |
quantitative PCR
|
17922033 |
Cancer - 0 (Leiomyosarcoma - 0) |
Cancer |
muscle |
miRNA downregulation |
- |
12.5 |
- |
Patient study phenotype-control |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16737555 |
- |
- |
fibroblast |
miRNA overexpression |
- |
- |
- |
Bioprocess study |
miRNA microarray
|
16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|
18607389 |
- |
- |
embryo |
miRNA overexpression |
- |
1.28 |
- |
Bioprocess study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
17191223 |
- |
- |
lung |
miRNA downregulation |
- |
- |
- |
Bioprocess study |
quantitative PCR
|